CSF1 and breast cancer: Administration of CSF-1 antisense oligodeoxyribonucleotide and siRNA directed against CSF-1 mRNA or host (mouse) CSF-1 receptors to mice bearing human breast cancer xenografts suppressed tumor growth by 40–50% and increased mouse survival.